Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription 04.03.2019 1 Antimicrob Agents Chemother 1 Clin Infect Dis 14 Int J Tuberc Lung Dis 1 J Infect 2 Lancet 2 Lancet Glob Health 2 PLoS Med 7 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. SARATHY J, Blanc L, Alvarez-Cabrera N, O'Brien P, et al
   Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations.
   Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02516.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. PERUMAL R, Padayatchi N, Yende-Zuma N, Naidoo A, et al
   A moxifloxacin-based regimen for the treatment of recurrent drug-sensitive pulmonary tuberculosis: An open-label randomised controlled trial.
   Clin Infect Dis. 2019 Feb 27. pii: 5365529. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Int J Tuberc Lung Dis

3. KWAK N, Kim HR, Yoo CG, Kim YW, et al
   Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes.
   Int J Tuberc Lung Dis. 2019;23:174-180.
   PubMed     Text format     Abstract available
   
   
4. CHIN AT, Rylance J, Makumbirofa S, Meffert S, et al
   Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.
   Int J Tuberc Lung Dis. 2019;23:203-211.
   PubMed     Text format     Abstract available
   
   
5. FIOGBE AA, Agodokpessi G, Tessier JF, Affolabi D, et al
   Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.
   Int J Tuberc Lung Dis. 2019;23:195-202.
   PubMed     Text format     Abstract available
   
   
6. ENDALAMAW A, Ambachew S, Geremew D, Habtewold TD, et al
   HIV infection and unknown HIV status among tuberculosis patients in Ethiopia: a systematic review and meta-analysis.
   Int J Tuberc Lung Dis. 2019;23:187-194.
   PubMed     Text format     Abstract available
   
   
7. MURAKAMI R, Matsuo N, Ueda K, Nakazawa M, et al
   Epidemiological and spatial factors for tuberculosis: a matched case-control study in Nagata, Japan.
   Int J Tuberc Lung Dis. 2019;23:181-186.
   PubMed     Text format     Abstract available
   
   
8. ZURITA J, Espinel N, Barba P, Ortega-Paredes D, et al
   Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador.
   Int J Tuberc Lung Dis. 2019;23:166-173.
   PubMed     Text format     Abstract available
   
   
9. COX V, Cox H, Pai M, Stillo J, et al
   Health care gaps in the global burden of drug-resistant tuberculosis.
   Int J Tuberc Lung Dis. 2019;23:125-135.
   PubMed     Text format     Abstract available
   
   
10. COELHO DA SILVA FD, Covre LP, Stringari LL, Palaci M, et al
    Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjects.
    Int J Tuberc Lung Dis. 2019;23:212-218.
    PubMed     Text format     Abstract available
    
    
11. LUO J, Luo M, Li J, Yu J, et al
    Rapid direct drug susceptibility testing of Mycobacterium tuberculosis based on culture droplet digital polymerase chain reaction.
    Int J Tuberc Lung Dis. 2019;23:219-225.
    PubMed     Text format     Abstract available
    
    
12. GOLLI AL, Nitu MF, Turcu F, Popescu M, et al
    Tuberculosis remains a public health problem in Romania.
    Int J Tuberc Lung Dis. 2019;23:226-231.
    PubMed     Text format     Abstract available
    
    
13. HARRIES AD, Schwoebel V, Monedero-Recuero I, Aung TK, et al
    Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
    Int J Tuberc Lung Dis. 2019;23:241-251.
    PubMed     Text format     Abstract available
    
    
14. HOOD G, Trieu L, Ahuja SD
    Mortality among tuberculosis patients in New York City.
    Int J Tuberc Lung Dis. 2019;23:252-259.
    PubMed     Text format     Abstract available
    
    
15. MAZZARELLI A, Cannas A, Venditti C, D'Arezzo S, et al
    Clinical evaluation of TRCReady M.TB for rapid automated detection of M. tuberculosis complex in respiratory samples.
    Int J Tuberc Lung Dis. 2019;23:260-264.
    PubMed     Text format     Abstract available
    
    
16. ZHANG RR, Liang L, Chen WW, Wen C, et al
    ULK1 polymorphisms confer susceptibility to pulmonary tuberculosis in a Chinese population.
    Int J Tuberc Lung Dis. 2019;23:265-271.
    PubMed     Text format     Abstract available
    
    

    
    J Infect

17. WANG G, Wang S, Jiang G, Yang X, et al
    Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study.
    J Infect. 2019 Feb 20. pii: S0163-4453(19)30059.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

18. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Text format     Abstract available
    
    
19. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed     Text format    
    
    

    
    Lancet Glob Health

20. AMBERBIR A
    The challenge of worldwide tuberculosis control: and then came diabetes.
    Lancet Glob Health. 2019 Feb 25. pii: S2214-109X(19)30053.
    PubMed     Text format    
    
    
21. NOUBIAP JJ, Nansseu JR, Nyaga UF, Nkeck JR, et al
    Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis.
    Lancet Glob Health. 2019 Feb 25. pii: S2214-109X(18)30487.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

22. MABUD TS, de Lourdes Delgado Alves M, Ko AI, Basu S, et al
    Correction: Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from Brazil.
    PLoS Med. 2019;16:e1002764.
    PubMed     Text format     Abstract available
    
    
23. SUBBARAMAN R, Nathavitharana RR, Mayer KH, Satyanarayana S, et al
    Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care.
    PLoS Med. 2019;16:e1002754.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

24. LOPEZ-GARNIER S, Sheen P, Zimic M
    Automatic diagnostics of tuberculosis using convolutional neural networks analysis of MODS digital images.
    PLoS One. 2019;14:e0212094.
    PubMed     Text format     Abstract available
    
    
25. GUALANO G, Mencarini P, Musso M, Mosti S, et al
    Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    PLoS One. 2019;14:e0212948.
    PubMed     Text format     Abstract available
    
    
26. DENEGRE AA, Ndeffo Mbah ML, Myers K, Fefferman NH, et al
    Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients.
    PLoS One. 2019;14:e0212969.
    PubMed     Text format     Abstract available
    
    
27. IWAMOTO T, Murase Y, Yoshida S, Aono A, et al
    Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0212798.
    PubMed     Text format     Abstract available
    
    
28. NGUYEN DT, Agarwal S, Graviss EA
    Trends of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis.
    PLoS One. 2019;14:e0212729.
    PubMed     Text format     Abstract available
    
    
29. SOEROTO AY, Lestari BW, Santoso P, Chaidir L, et al
    Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    PLoS One. 2019;14:e0213017.
    PubMed     Text format     Abstract available
    
    
30. FAN X, Li N, Wang X, Zhang J, et al
    Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection.
    PLoS One. 2018;13:e0203678.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: